Regulation of Catechol-O-Methyltransferase Expression in Human Myometrial Cells
Authors:
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 108 (6) , 1439-1447
Abstract
OBJECTIVE: The catechol-O-methyltransferase enzyme catalyzes the methylation of the catechol estrogens, 2- or 4-hydroxyestrogen, to 2- or 4-methoxyestrogen. Both the hydroxy estrogens and methoxy estrogens were shown to modulate the effects of estrogen. Because catechol-O-methyltransferase activity controls levels of these metabolites, it may help regulate the cellular estrogenic milieu. In this study, we examined the regulation of catechol-O-methyltransferase expression in human myometrial cells. METHODS: Catechol-O-methyltransferase expression was assessed by reverse transcription–polymerase chain reaction, Western blot, and luciferase assays in human myometrial cells after treatment with estrogen or progesterone. Catechol-O-methyltransferase expression was measured in cells after treatment with tumor necrosis factor alpha (TNFα) alone or with lactacystin, a proteasome inhibitor. Luciferase assays were also conducted using human myometrial cells containing an estrogen response element–luciferase reporter gene to measure levels of estrogen-mediated transactivation after treatment with estrogen and increasing concentrations of 2-hydroxestrogen. RESULTS: Catechol-O-methyltransferase expression was down-regulated by progesterone or estrogen. Tumor necrosis factor alpha upregulated catechol-O-methyltransferase expression, whereas cotreatment with lactacystin attenuated this response, suggesting that TNFα activated nuclear factor kappa B to induce catechol-O-methyltransferase expression. Increased concentrations of 2-hydroxyestrogen attenuated estrogen-mediated transcription in the myometrial cells. CONCLUSION: Catechol-O-methyltransferase expression may be regulated in the myometrium to control the local action of estrogen. Low levels of catechol-O-methyltransferase in the myometrium would result in an accumulation of 2-hydroxyestrogen and may antagonize the local effect of estrogen. High levels of catechol-O-methyltransferase in the myometrium would result in lower levels of 2-hydroxyestrogen and may increase sensitivity to estrogen.Keywords
This publication has 27 references indexed in Scilit:
- Catechol-O-Methyltransferase Polymorphism Is Associated With Increased Uterine Leiomyoma Risk in Different Ethnic GroupsJournal of the Society for Gynecologic Investigation, 2006
- 2-Methoxyestradiol Is an Estrogen Receptor Agonist That Supports Tumor Growth in Murine Xenograft Models of Breast CancerClinical Cancer Research, 2005
- Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude miceAmerican Journal of Obstetrics and Gynecology, 2004
- Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cellsAmerican Journal of Obstetrics and Gynecology, 1995
- Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone.Journal of Histochemistry & Cytochemistry, 1991
- Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiationMolecular and Cellular Endocrinology, 1989
- Catechol-O-Methyl Transferase Activity in the Human Term PlacentaAmerican Journal of Perinatology, 1988
- Hormonal influences on erythrocyte catechol-O-methyl transferase activity in humansCellular and Molecular Life Sciences, 1973